Bunkerhill MAC vs vascuCAP
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are adjacent competitors in cardiovascular risk assessment, both leveraging AI and CT scans. Bunkerhill MAC specifically targets the detection and quantification of mitral annular calcification on routine CTs, aiding early risk identification. In contrast, vascuCAP provides detailed plaque composition analysis and 3D visualization from CT angiography for broader arterial risk stratification and treatment optimization.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Bunkerhill MAC is designed to detect and quantify mitral annular calcification (MAC) on routine CT scans, aiding in early cardiovascular risk identification. vascuCAP (now ElucidVivo/PlaqueIQ) quantifies plaque composition and assesses cardiovascular risk to optimize treatment decisions for conditions like stroke and heart attack.
Bunkerhill MAC analyzes routine, non-gated chest CT scans. vascuCAP processes CT angiography (CTA) to characterize plaque tissues.
Bunkerhill MAC specifically detects and quantifies Mitral Annular Calcification (MAC). vascuCAP quantifies lipid-rich necrotic core, calcification, non-calcified matrix, and intraplaque hemorrhage, providing histologically-validated plaque characterization.
Bunkerhill MAC integrates with the Carebricks generative AI platform for clinical reasoning and action, supporting automated workflows for follow-up and care coordination. vascuCAP provides risk stratification for stroke and heart attack, supporting personalized treatment decisions and offering 3D visualization of arterial vessels and plaque.
Bunkerhill MAC was developed and validated through a multi-institutional research consortium. vascuCAP features histologically-validated plaque quantification and characterization, with its algorithms validated by expert pathologists using a biobank of tissue specimens.